As of 2026-05-26, the Fair Value of Jacobio Pharmaceuticals Group Co Ltd (1167.HK) is -5.27 HKD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.32 HKD, the upside of Jacobio Pharmaceuticals Group Co Ltd is -198.98%.
With the market price of 5.32 HKD and our fair value calculation, Jacobio Pharmaceuticals Group Co Ltd (1167.HK) is not a good investment. Investing in 1167.HK stocks now will result in a potential loss of 198.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -301.19 | -371.86 | -359.12 | -155.71 | -145.98 | -266.77 |
| YoY growth | 80.10% | -23.47% | 3.43% | 56.64% | 6.25% | 24.59% |
| Market Cap (mil) | 4,180.08 |
| P/E | |
| Forward P/E |
| EPS | -0.19 |
| Avg earnings growth rate | 24.59% |
| TTM earnings | -145.98 |